Global Prevalence and Incidence of Amyotrophic Lateral Sclerosis
Глобальная распространенность и заболеваемость боковым амиотрофическим склерозом
2023-06-12
SCID: 54.1/twt9csad
Discuss with AI
amyotrophic lateral sclerosisglobal epidemiologyincidencepoint prevalencesystematic review
Figures from the paper
Abstract (AI)
BACKGROUND AND OBJECTIVES: Amyotrophic lateral sclerosis (ALS) is a rare neurodegenerative disorder affecting upper and lower motor neurons. Due to its rarity and rapidly progressive nature, studying the epidemiology of ALS is challenging, and a comprehensive picture of the global burden of this disease is lacking. The objective of this systematic review was to describe the global incidence and prevalence of ALS. METHODS: We searched MEDLINE, Embase, Global Health, PsycInfo, Cochrane Library, and CINAHL to identify articles published between January 1, 2010, and May 6, 2021. Studies that were population based and reported estimates of prevalence, incidence, and/or mortality of ALS were eligible for inclusion. This study focuses on the incidence and prevalence. Quality assessment was performed using a tool developed to evaluate methodology relevant to prevalence and incidence studies. This review was registered with PROSPERO, CRD42021250559. RESULTS: This search generated 6,238 articles, of which 140 were selected for data extraction and quality assessment. Of these, 85 articles reported on the incidence and 61 on the prevalence of ALS. Incidence ranged from 0.26 per 100,000 person-years in Ecuador to 23.46 per 100,000 person-years in Japan. Point prevalence ranged from 1.57 per 100,000 in Iran to 11.80 per 100,000 in the United States. Many articles identified cases with ALS from multiple data sources. DISCUSSION: There is variation in reported incidence and prevalence estimates of ALS across the world. While registries are an important and powerful tool to quantify disease burden, such resources are not available everywhere. This results in gaps in reporting of the global epidemiology of ALS, as highlighted by the degree of variation (and quality) in estimates of incidence and prevalence reported in this review.
Key Findings
1
Many studies identified ALS cases using multiple data sources, including registries where available.
2
Reported ALS incidence varied widely, from 0.26 per 100,000 person-years in Ecuador to 23.46 per 100,000 person-years in Japan.
3
Reported point prevalence ranged from 1.57 per 100,000 in Iran to 11.80 per 100,000 in the United States.
4
Substantial geographic variation and uneven study quality reveal major gaps in global ALS epidemiologic reporting, partly because registries are unavailable in many regions.
5
This systematic review identified 140 population-based studies published from 2010 to 2021 assessing global ALS epidemiology.
Research Object
Amyotrophic lateral sclerosis (ALS) in human populations worldwide
Research Subject
Global incidence and prevalence of ALS
Publication Details
Publication Date
2023-06-12
Journal
Publisher
ISSN
Cited by
161
Open access PDF
Access Type
Author Information
Download PDF
Subscribe to digest
References available in scid.ai3
R: A Language and Environment for Statistical Computing2000
Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990–2016: a systematic analysis for the Global Burden of Disease Study 20162017
The burden of neurological diseases in Europe: an analysis for the Global Burden of Disease Study 20172020